• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[2023年现代选择性内放射治疗——从姑息治疗到一种根治性治疗选择]

[Modern TARE 2023 - from palliative care to a curative treatment alternative].

作者信息

Gebauer Bernhard, Collettini Federico, Pfob Christian Helmut, Lapa Constantin

机构信息

Radiology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Berlin Institute of Health at Charite, Berlin, Germany.

出版信息

Nuklearmedizin. 2024 Dec;63(6):328-336. doi: 10.1055/a-2353-5819. Epub 2024 Jul 16.

DOI:10.1055/a-2353-5819
PMID:39013456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614522/
Abstract

Selective internal radiotherapy (SIRT) or transarterial radioembolisation (TARE) is an alternative treatment for hepatocellular carcinoma (HCC) or hepatic metastatic colorectal carcinoma (mCRC) and is now anchored in many guidelines. The article summarises the current guidelines on SIRT/TARE in HCC and mCRC.

摘要

选择性体内放射疗法（SIRT）或经动脉放射性栓塞术（TARE）是肝细胞癌（HCC）或肝转移性结直肠癌（mCRC）的一种替代治疗方法，目前已被纳入许多指南。本文总结了关于HCC和mCRC的SIRT/TARE的现行指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12dd/11614522/475074178bd2/10-1055-a-2353-5819_23552322.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12dd/11614522/475074178bd2/10-1055-a-2353-5819_23552322.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12dd/11614522/475074178bd2/10-1055-a-2353-5819_23552322.jpg

相似文献

1
[Modern TARE 2023 - from palliative care to a curative treatment alternative].[2023年现代选择性内放射治疗——从姑息治疗到一种根治性治疗选择]
Nuklearmedizin. 2024 Dec;63(6):328-336. doi: 10.1055/a-2353-5819. Epub 2024 Jul 16.
2
Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?社论：转移性结直肠癌的放射性栓塞治疗：终于走向成熟了吗？
Curr Opin Oncol. 2021 Jul 1;33(4):351-352. doi: 10.1097/CCO.0000000000000749.
3
Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.不可切除肝细胞癌的治疗选择，重点是使用钇-90树脂微球的选择性内放射治疗（SIRT）
Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.12972. Epub 2017 Jul 30.
4
Transarterial Radioembolisation with Y90 Resin Microspheres and the Effect of Reimbursement Criteria in France: Final Results of the CIRT-FR Prospective Observational Study.使用钇-90树脂微球进行经动脉放射性栓塞治疗以及法国报销标准的影响：CIRT-FR前瞻性观察研究的最终结果
Cardiovasc Intervent Radiol. 2025 Feb;48(2):205-220. doi: 10.1007/s00270-024-03955-y. Epub 2025 Jan 14.
5
Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation.经动脉放射性栓塞术治疗化疗栓塞难治性中晚期肝细胞癌的安全性和有效性
Cardiovasc Intervent Radiol. 2017 Dec;40(12):1882-1890. doi: 10.1007/s00270-017-1739-5. Epub 2017 Jul 6.
6
Radioembolisation for treatment of pediatric hepatocellular carcinoma.放射性栓塞治疗小儿肝细胞癌。
Pediatr Radiol. 2013 Jul;43(7):876-81. doi: 10.1007/s00247-012-2568-y. Epub 2012 Dec 5.
7
Prognostic value of lung shunt fraction in hepatocellular carcinoma and unresectable liver dominant metastatic colorectal cancer undergoing transarterial radioembolisation.经肝动脉放射栓塞术治疗肝细胞癌和不可切除肝转移结直肠癌中肺分流分数的预后价值。
Nucl Med Commun. 2022 Jan 1;43(1):24-31. doi: 10.1097/MNM.0000000000001492.
8
Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma.经动脉放射栓塞治疗后对肝癌患者生存结局的影响。
Cancer Invest. 2021 Mar;39(3):274-283. doi: 10.1080/07357907.2020.1870126. Epub 2021 Jan 11.
9
Radioembolization of HCC and secondary hepatic tumors: a comprehensive review.肝细胞癌和继发性肝肿瘤的放射性栓塞：全面综述。
Q J Nucl Med Mol Imaging. 2024 Dec;68(4):270-287. doi: 10.23736/S1824-4785.24.03572-6. Epub 2024 Aug 1.
10
Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.Y90 放射性栓塞治疗经动脉栓塞治疗后的肝细胞癌患者的结果。
Curr Oncol. 2024 May 8;31(5):2650-2661. doi: 10.3390/curroncol31050200.

本文引用的文献

1
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
2
Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria.放射性栓塞治疗肝细胞癌的临床疗效优化：剂量学和患者选择标准。
Curr Oncol. 2022 Mar 29;29(4):2422-2434. doi: 10.3390/curroncol29040196.
3
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
BCLC 策略用于预后预测和治疗推荐：2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
4
Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review.放射性栓塞治疗肝细胞癌的演变：影像学综述。
Radiographics. 2021 Oct;41(6):1802-1818. doi: 10.1148/rg.2021210014. Epub 2021 Sep 24.
5
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.化疗栓塞联合放射栓塞治疗结直肠癌肝转移：一项随机、开放标签、国际、多中心、三期临床试验。
J Clin Oncol. 2021 Dec 10;39(35):3897-3907. doi: 10.1200/JCO.21.01839. Epub 2021 Sep 20.
6
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study.钇-90 放射性栓塞治疗不可切除单发 HCC：LEGACY 研究。
Hepatology. 2021 Nov;74(5):2342-2352. doi: 10.1002/hep.31819. Epub 2021 Jun 11.
7
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.个体化与标准剂量测定法在局部进展期肝细胞癌患者选择性内放射治疗中的应用（DOSISPHERE-01）：一项随机、多中心、开放标签的 2 期试验。
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. doi: 10.1016/S2468-1253(20)30290-9. Epub 2020 Nov 7.
8
Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Y in the SARAH Study.SARAH 研究中钇[90Y]放射性微球内放射栓塞治疗肝细胞癌的肿瘤吸收剂量与生存和反应的关系。
Radiology. 2020 Sep;296(3):673-684. doi: 10.1148/radiol.2020191606. Epub 2020 Jun 30.
9
Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.钇-90 选择性内放射治疗在以肝脏为主的转移性结直肠癌治疗中的作用：基于证据的专家共识算法
J Gastrointest Oncol. 2020 Apr;11(2):443-460. doi: 10.21037/jgo.2020.01.09.
10
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.钇-90微球放射性栓塞治疗不可切除的肝细胞癌
Cochrane Database Syst Rev. 2020 Jan 24;1(1):CD011313. doi: 10.1002/14651858.CD011313.pub3.